Showing results (1-10 of 11) with videos related to
Sort By:
Pageof 2
Zhong Nan Da Xue Xue Bao. Yi Xue Ban = Journal of Central South University. Medical Sciences|April 25, 2026
[Therapeutic efficacy of ASS1 combined with LOLA in the treatment of hyperammonemia in mice]Tiao Luo, Zhengnan Ming, Zizheng Zou, et al.Frontiers in Oncology|May 1, 2023
Clustering analysis and prognostic model based on PI3K/AKT-related genes in pancreatic cancerXiangying Deng, Xu He, Zehua Yang, et al.Acta Biochimica Et Biophysica Sinica|October 31, 2020
ARG1 functions as a tumor suppressor in breast cancerZhengnan Ming, Zizheng Zou, Kaimei Cai, et al.Acta Biochimica Et Biophysica Sinica|May 31, 2025
LM2I leads to CAD ubiquitination and liver cancer suppression through activation of ASS1Zhengnan Ming, Tiao Luo, Zizheng Zou, et al.Hepatology Communications|August 18, 2025
ASS1 inhibits liver cancer by promoting CAD ubiquitination and reversing the urea cycle and pyrimidine synthesis imbalanceZhengnan Ming, Tiao Luo, Zizheng Zou, et al.Cancers|May 13, 2023
An Isoxazoloquinone Derivative Inhibits Tumor Growth by Targeting STAT3 and Triggering Its Ubiquitin-Dependent DegradationYuanzhu Xie, Shuaiwen Zhu, Ling Chen, et al.Oncotarget|March 12, 2016
ZLM-7 exhibits anti-angiogenic effects via impaired endothelial cell function and blockade of VEGF/VEGFR-2 signalingMin Su, Jingjia Huang, Jijia Li, et al.Cell Death & Disease|May 6, 2024
ASS1 inhibits triple-negative breast cancer by regulating PHGDH stability and de novo serine synthesisWensong Luo, Zizheng Zou, Yuan Nie, et al.Journal of Natural Products|September 8, 2023
Spinosyn A and Its Derivative Inhibit Colorectal Cancer Cell Growth via the EGFR PathwayKunjian Peng, Zizheng Zou, Jijia Li, et al.Scientific Reports|November 18, 2024
Naphthoquinone-derived ZSW-4B induces apoptosis in triple-negative breast cancer via AMPK signalling activationXiyuan Hu, Hongdou Liu, Tiao Luo, et al.Pageof 2